Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) EBITDA: 2018-2024

Historic EBITDA for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to -$2.5 million.

  • Legend Biotech's EBITDA rose 31.48% to -$43.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.2 million, marking a year-over-year increase of 79.17%. This contributed to the annual value of -$2.5 million for FY2024, which is 98.95% up from last year.
  • Legend Biotech's EBITDA amounted to -$2.5 million in FY2024, which was up 98.95% from -$241.2 million recorded in FY2023.
  • Over the past 5 years, Legend Biotech's EBITDA peaked at -$2.5 million during FY2024, and registered a low of -$406.3 million during FY2021.
  • Its 3-year average for EBITDA is -$149.0 million, with a median of -$203.4 million in 2022.
  • In the last 5 years, Legend Biotech's EBITDA tumbled by 139.25% in 2020 and then skyrocketed by 98.95% in 2024.
  • Legend Biotech's EBITDA (Yearly) stood at -$304.1 million in 2020, then tumbled by 33.62% to -$406.3 million in 2021, then soared by 49.94% to -$203.4 million in 2022, then decreased by 18.59% to -$241.2 million in 2023, then soared by 98.95% to -$2.5 million in 2024.